X
API Suppliers
US DMFs Filed
CEP/COS Certifications
JDMFs Filed
Other Certificates
Other Suppliers
USA (Orange Book)
Europe
Canada
Australia
0
South Africa
Uploaded Dossiers
U.S. Medicaid
Annual Reports
https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-august-9-2023-9584.pdf
https://www.fda.gov/drugs/drug-safety-and-availability/fda-warns-consumers-tydemy-prescription-oral-contraceptive-may-have-reduced-effectiveness#:~:text=%5BAugust%201%2C%202023%5D%20FDA,an%20ingredient%2C%20in%20the%20product.
https://www.fda.gov/safety/recalls-market-withdrawals-safety-alerts/lupin-pharmaceuticals-inc-issues-voluntary-nationwide-recall-2-lots-tydemytm-drospirenone-ethinyl
https://www.fda.gov/safety/recalls-market-withdrawals-safety-alerts/lupin-pharmaceuticals-inc-issues-voluntary-nationwide-recall-2-lots-tydemytm-drospirenone-ethinyl
https://www.prnewswire.com/news-releases/lupin-pharmaceuticals-inc-issues-voluntary-nationwide-recall-of-2-lots-of-tydemytm-drospirenone-ethinyl-estradiol-and-levomefolate-calcium-tablets-3mg0-03mg0-451mg-and-levomefolate-calcium-tablets-0-451mg-due-to-out-of-spec-301888778.html
https://www.reuters.com/business/healthcare-pharmaceuticals/germanys-bayer-faces-shortage-contraceptive-pill-yasmin-india-2023-06-06/
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=216936
https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/lupin-gets-usfda-nod-for-generic-oral-contraceptive-pill/articleshow/95296634.cms
https://www.europeanpharmaceuticalreview.com/news/175321/first-oral-combined-estetrol-contraceptive-available-in-uk/
https://www.pharmatimes.com/news/gedeon_richter_announces_availability_of_oral_contraception_drovelis_1459350
https://www.globenewswire.com/news-release/2022/05/17/2444760/0/en/Slynd-drospirenone-a-new-progestin-only-contraceptive-pill-from-Duchesnay-which-offers-a-24-hour-safe-window-for-a-missed-pill.html
https://www.expresspharma.in/lupin-recalls-4113-cartons-of-oral-contraceptive-medicine-in-us-market/
https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/lupin-recalls-4113-cartons-of-oral-contraceptive-medicine-in-us-market/articleshow/88236402.cms
https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-december-08-2021-1638945311.pdf
https://www.prnewswire.com/news-releases/new-data-show-nextstellis-has-selective-impact-on-endocrine-markers-compared-with-common-combined-oral-contraceptives-301241886.html#:~:text=RALEIGH%2C%20N.C.%2C%20March%206%2C,including%20lower%20increases%20in%20hormone
https://www.prnewswire.com/news-releases/two-new-publications-support-the-safety-and-efficacy-of-slynd-drospirenone-tablets-4-mg-301088590.html
https://www.prnewswire.com/news-releases/peer-reviewed-publication-reinforces-safety-and-efficacy-of-slynd-drospirenone-tablets-4-mg-301073960.html
https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-august-7-2019-1565155577.pdf
https://www.in-pharmatechnologist.com/Article/2019/08/06/Jubilant-recalls-contraceptives
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=202318
https://www.pharmacompass.com/pdf/news/jubilant-cadista-issues-voluntary-nationwide-recall-of-drospirenone-and-ethinyl-estradiol-tablets-usp-1564083915.pdf
https://www.prnewswire.com/news-releases/exeltis-usa-inc-announces-the-approval-of-slynd-the-first-and-only-progestin-only-pill-providing-pregnancy-prevention-with-a-244-dosing-regimen-and-24-hour-missed-pill-window-300863390.html
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=211944
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=202138
https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-march-13-2019-1552453797.pdf
https://www.pharmacompass.com/pdf/news/apotex-corp-issues-recalls-of-drospirenone-and-ethinyl-estradiol-tablets-1551769735.pdf
https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/lupin-launches-contraceptive-drug-in-the-us-market/articleshow/65560450.cms
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=205947
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=209407
http://www.business-standard.com/article/companies/lupin-gets-usfda-nod-for-contraceptive-tablet-tydemy-for-women-118031300647_1.html
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=209423
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=205948
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=203291
http://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=207245
https://www.pharmacompass.com/pdf/news/apotex-inc-generic-drospirenone-ethinyl-estradio-approved-in-us-1474699881.pdf
http://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/glenmark-pharmaceuticals-gets-two-anda-approvals-from-usfda/articleshow/51581733.cms
https://www.pharmacompass.com/pdf/news/jais-generic-drospirenone-ethinyl-estradiol-approved-in-us-for-contraception-1446115825.pdf
http://www.prnewswire.com/news-releases/mylan-launches-generic-yasmin-tablets-300138815.html
http://www.business-standard.com/article/markets/glenmark-pharma-hits-new-high-on-usfda-nod-for-drospirenone-and-ethinyl-estradiol-tablets-115081900118_1.html?
Market Place
Share 
